In addition, CYP2A6 activates multiple tobacco procarcinogens including 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK), leading to liver damage and lung cancer [5]. The gene discussed is CYP2A6; the disease is lung carcinoma.